Composition for preventing or treating spinal cord injury comprising imidazole-poly(organophosphazene) hydrogel
View Patent ↗The present disclosure relates to a pharmaceutical composition for preventing or treating spinal cord injury comprising an imidazole-poly(organophosphazene) hydrogel or a pharmaceutically acceptable salt thereof, a method for preventing or treating spinal cord injury, and a food composition for preventing or ameliorating spinal cord injury. The imidazole-poly(organophosphazene) hydrogel of the present disclosure has the effect of regenerating the extracellular matrix (ECM) by filling cystic cavities and can thus be effectively used for the prevention and treatment of spinal cord injury by a simple injection method.
1. A method for treating spinal cord injury comprising administering a compound of Formula 1 below or a pharmaceutically acceptable salt thereof to a subject in need thereof:
wherein, in Formula 1 above,
p is in a range of 16 to 50,
a, b, c, and d are values representing the amount of each substituent, which are each in a range of 0.01 to 1.9,
the sum of (a+b+c+d) is 2, and
n is a polymerization degree of polyphosphazene, which is in a range of 5 to 100,000.
2. The method of claim 1 , wherein the compound of Formula 1 or pharmaceutically acceptable salt thereof removes cystic cavities in the spinal cord.
3. The method of claim 1 , wherein the compound of Formula 1 or pharmaceutically acceptable salt thereof promotes regeneration of extracellular matrix (ECM).
4. The method of claim 1 , wherein the spinal cord injury is at least one selected from the group consisting of flexion injury, vertical compression injury, hyperextension injury, flexion rotation injury, acute transverse myelitis, acute disseminated encephalomyelitis, myelopathy, non-Hodgkin's lymphoma, hydrocephalus, hereditary ataxia, neurosyphilis, Minamata disease, amyotrophic lateral sclerosis, and multiple sclerosis.
5. The method of claim 1 , wherein the compound of Formula 1 or pharmaceutically acceptable salt thereof is able to treat spinal cord injury without the administration of additional cells or protein.
6. The method of claim 1 , wherein the administration is an administration of a composition comprising the compound of Formula 1 or pharmaceutically acceptable salt thereof.
7. The method of claim 1 , wherein the treatment is to ameliorate spinal cord injury.
8. A method for removing cystic cavities in the spinal cord comprising administering the compound of Formula 1 below or pharmaceutically acceptable salt thereof to a subject in need thereof:
wherein, in Formula 1 above,
p is in a range of 16 to 50,
a, b, c, and d are values representing the amount of each substituent, which are each in a range of 0.01 to 1.9,
the sum of (a+b+c+d) is 2, and
n is a polymerization degree of polyphosphazene, which is in a range of 5 to 100,000.